Article Information
History
- September 30, 2021.
Article Versions
- Version 1 (September 29, 2021 - 08:55).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Rohan Khera, MD MS1,2,
- Martijn J Scheumie, PhD3,4,
- Yuan Lu, ScD1,2,
- Anna Ostropolets, MD5,
- Ruijun Chen, MD6,
- George Hripcsak, MD MS5,7,
- Patrick B Ryan, PhD3,5,
- Harlan M Krumholz, MD SM1,2 and
- Marc A Suchard, MD PhD4,8,9,10,*
- 1Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
- 2Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT
- 3Epidemiology Analytics, Janssen Research and Development, Titusville, NJ
- 4Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, CA
- 5Department of Biomedical Informatics, Columbia University Medical Center, New York, NY
- 6Department of Translational Data Science and Informatics, Geisinger, Danville, PA
- 7New York-Presbyterian Hospital, New York, NY
- 8Department of Biomathematics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA
- 9Department of Human Genetics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA
- 10VA Informatics and Computing Infrastructure, Department of Veterans Affairs, Salt Lake City, UT
- ↵*Corresponding author; email: msuchard{at}ucla.edu
Posted September 30, 2021.
RESEARCH PROTOCOL: Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus
